Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Mucositis × CBLB502 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other 1 Head & Neck 1

Conditions

Tongue Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Mucositis 1

Interventions

angiotensin I (1-7) 2 apraglutide 1 Vaccinium myrtillus extract 1 Radiotherapy, Intensity-Modulated 1 Lansoprazole 1 Fibroblast Growth Factor 7 1 Dexlansoprazole 1 Cisplatin 1 CBLB502 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01728480 2013-12-11

Entolimod in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer Receiving Cisplatin and Radiation Therapy

Roswell Park Cancer Institute

Phase 1 Withdrawn

Head & NeckOther

Squamous Cell Carcinoma of Head and Neck, Tongue Neoplasms, Mucositis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡